Biocortech: Novel therapeutics for neuropsychiatry
The company uses innovative technology which reconnects neural circuits and repairs deficient receptors. This approach to neuropsychiatric disease will provide novel solutions for the increasing number of patients for whom traditional medicine proves unsuccessful. Biocortech has filed for an initial patent for the repair of dysfunctional neural receptors. A leading pharmaceutical laboratory has already signed two collaboration contracts with Biocortech concerning the development of a lead, selected by Biocortech and the research of new molecules active on depression. Biocortech already has a significant revenue stream. Its business model is based on the parallel development of a number of molecules up to phase I/IIa, which will then be licensed to pharmaceutical companies, to ensure regular revenues. The company is active in a number of areas that could be of interest: ,- Novel therapeutics for diseases affecting the central nervous system,- Drug discovery,- Pharmacogenomics,- Biotechnology Any feedback about your particular areas of interest and whether you would be interested in receiving further news from Biocortech. If it is of interest, we would be delighted to arrange a meeting with Dinah Weissmann, CEO and/or Jean-François Pujol, chief scientific officer of Biocortech, who together have more than 50 years academic and industrial research experience.About Biocortech,Biocortech develops novel therapies for diseases affecting the central nervous system, including depression, schizophrenia, cognitive degeneration due to the aging process, and sexual dysfunction. The company uses innovative technology which reconnects neural circuits and repairs deficient receptors. Biocortech was founded in November 2001 by Dinah Weissmann and Jean-Francois Pujol. Together, Weissmann and Pujol have more than 50 years experience in R&D in the area of the central nervous system, having worked with the CNRS, France's national centre for scientific research, and the Roussel Uclaf laboratories. Biocortech is headquartered at the Institut Pasteur's incubator, Pasteur Biotop, and benefits from the first class scientific and economic surroundings.
Paesi
France